Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRuE-V LTE: Ruxolitinib Cream Extension in Vitiligo
NCT04530344Phase 3Completed
- Sponsor
- Incyte
- Start
- Sep 2020
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of ruxolitinib cream in Vitiligo, sponsored by Incyte. Started Sep 2020; status: completed.
02
Drugs
ruxolitinib cream
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT04530344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04530344.